19 January 2018
News and Views
Links and Services
A study in the latest issue of the Alimentary Pharmacology & Therapeutics finds a reduction in hepatic events following interferon-alfa therapy of chronic hepatitis B.
The long-term benefit of interferon-alfa (IFN-α) treatment in preventing various hepatic com
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors